期刊
NANOMEDICINE
卷 13, 期 2, 页码 209-232出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2017-0220
关键词
chylomicrons (CM); Ehrlich ascites carcinoma (EAC); liver cancer; luteolin (LUT); mouse model; phytochylomicron (LPC CM)
Aim: A novel luteolin (LUT) loaded dual bionanocarrier 'hytochylomicron' was elaborated to allow LUT injectable delivery and liver cancer targeting. Methods: LUT-phospholipid complex was prepared and loaded into chylomicron nanocarrier. Then phytochylomicron underwent physicochemical characterization, cell culture and pharmacodynamics studies on a new liver-tumor model. Results: Phytochylomicron showed sustained release pattern with minimum drug leakage until reaching the liver. Cell culture studies showed high growth inhibition of Hep G2 cells with 2.6-fold enhancement in cellular uptake. Pharmacodynamics demonstrated enhanced tumor growth inhibition (sixfold) with a significant tumor size reduction. Finally, cell culture results demonstrated an excellent correlation with pharmacodynamics confirming the obtained findings. Conclusion: A novel phytochylomicron nanosystem was successfully elaborated with promising characteristics that promoted injectable LUT delivery and liver cancer targeting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据